Amgen Inc. Stock Rises Thursday, Outperforms Market

Artificial Intelligence Technology Solutions Inc

Change company Symbol lookup

Select an option...

AITX Artificial Intelligence Technology Solutions Inc

DPXCF DelphX Capital Markets Inc

HROWL HARROW HEALTH 8 625 SNR NTS

MLTX MoonLake Immunotherapeutics

TRTN Triton International Ltd

PAYA Paya Holdings Inc

MA Mastercard Inc

MWRK MetaWorks Platforms Inc

NSRGY Nestle SA

MIN MFS? Intermediate Income Fund

Company profile

Artificial Intelligence Technology Solutions Inc. is engaged in the delivery of artificial intelligence (AI) and robotic solutions for operational, security, and monitoring needs. The Company is focused on applying advanced AI-driven technologies, paired with multi-use hardware, and supported by custom software and cloud services, to intelligently automate and integrate a range of high-frequency security, concierge, and operational tasks. It owns and operates three wholly owned subsidiaries, which are Robotic Assistance Devices, Inc. (RAD I), Robotic Assistance Devices Group, Inc. (RAD G) and Robotic Assistance Devices Mobile, Inc. (RAD M). RAD I own the intellectual property related to RADSoC, RAD Mobile SOC, RADGuard, and their core operating architecture. RAD G is focused on the development of advanced software and electronics solutions. RAD M is focused on the development of autonomous mobile devices, both ground-based, and airborne. Its solutions are suited to various industries.

Amgen Inc. Stock Rises Thursday, Outperforms Market

4:36 pm ET November 17, 2022 (MarketWatch) Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Amgen Inc. (AMGN) advanced 1.24% to $287.30 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 0.31% to 3,946.56 and Dow Jones Industrial Average falling 0.02% to 33,546.32. This was the stock's second consecutive day of gains. Amgen Inc. closed $9.37 below its 52-week high ($296.67), which the company achieved on November 8th.

The stock outperformed some of its competitors Thursday, as Johnson & Johnson (JNJ) rose 0.81% to $174.86, Roche Holding AG Part. Cert. fell 3.72% to $312.94, and Pfizer Inc. (PFE) rose 0.58% to $48.33. Trading volume (2.2 M) remained 693,228 below its 50-day average volume of 2.9 M.

Data source: Dow Jones Market Data, FactSet. Data compiled November 17, 2022.

(END) Dow Jones Newswires

November 17, 2022 16:36 ET (21:36 GMT)